|
ÁÖÁ¦1 |
Depletion of CRBN gene enhance cardiac contraction |
ÁÖÁ¦2 |
AMPK in cardiac fibrosis and repair : Actions beyond metabolic regulation |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2017.01.13 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2017.01.13_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Tetrahydrobiopterin reverse heart and mitochondrial dysfunction through CaMK4/Akt pathway in late stage type 2 diabetic rats |
ÁÖÁ¦2 |
High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1) |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2017.01.06 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2017.01.06_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Á¦2 Çü ´ç´¢º´ À¯·¡ Ãʱ⠵¿¸Æ°æÈ¿¬±¸¸¦ À§ÇÑ ¸¶¿ì½º¸ðµ¨ÀÇ ±¸Ãà ¹× ¹ßº´±âÀü Ž»ö |
ÁÖÁ¦2 |
Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation |
ÁÖÁ¦3 |
Mitochondrial cereblon functions as a Lon-type protease |
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.12.30 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
3 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.12.30_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
CRBN in Multiple Myeloma |
ÁÖÁ¦2 |
|
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.12.23 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.12.23_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
NPS inhibits PDGF-BB induced VSMC proliferation |
ÁÖÁ¦2 |
New Insight into Atherosclerosis in Hemodialysis Patients: Overexpression of Scavenger Receptor and Macrophage Colony-Stimulating Factor Genes |
ÁÖÁ¦3 |
Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)¥ã-DEPENDENT MECHANISM |
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.12.16 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.12.16_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Cardioprotective effect of KL 1333 in rat ischemia reperfusion model |
ÁÖÁ¦2 |
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.12.09 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
1 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.12.09_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Cardiac myocyte remodeling in the face of diabetes and early-stage atherosclerosis |
ÁÖÁ¦2 |
A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.12.02 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.12.02_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Computational flow modeling of the left ventricle and aorta based on computed tomography data |
ÁÖÁ¦2 |
VEGF-A expressing adipose tissue shows rapid beiging, enhanced survival after transplantation and confers metabolic improvements on the host in an IL4-independent manner |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.11.25 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.11.25_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Regulating Mechanism of Mitochondrial Proteins through Post-translational Modifications |
ÁÖÁ¦2 |
The Implementation of Image-based Computational Modeling on the Atherosclerotic Coronary Artery |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.11.18 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.11.18_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
ÁÖÁ¦1 |
Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle |
ÁÖÁ¦2 |
Cereblon is a Direct Protein Target for Immunomodulatory and Antiproliferative activities of Lenalidomide and Pomalidomide |
ÁÖÁ¦3 |
|
¼¼¹Ì³ª¸í |
·¦¹ÌÆÃ |
°³ÃֱⰣ |
2016.11.11 |
°³ÃÖÀå¼Ò |
ÀÎÁ¦ÀÇ´ë ½ÉÇ÷°ü´ë»çÁúȯ¼¾ÅÍ Äھ |
¹ßÇ¥ÀÚ¼ö |
2 |
÷ºÎÆÄÀÏ |
Æ÷½ºÅÍ_-_2016.11.11_(±Ý)_·¦¹ÌÆÃ.ppt |
|
|
|
11 12 13 14 15 16 17 18  |